InvestorsHub Logo
Followers 1
Posts 41
Boards Moderated 0
Alias Born 08/27/2014

Re: louieblouie post# 150170

Wednesday, 10/17/2018 5:48:13 AM

Wednesday, October 17, 2018 5:48:13 AM

Post# of 425617
Great article. Thanks for posting. Particularly like how this author closes out the story (spoiler alert):

That puts it squarely on the menu for everyone even remotely suitable.

It’s a bit like the company just figured out how to genetically engineer trees that grow money. Imagine negotiating for the acquisition of a company that figured out how to engineer trees that grow money.

It’s not going to be easy to have the upper hand. But, if you’re Mega Pharmaceuticals Inc., you certainly don’t want to let Giganticus BioPharm Inc. beat you to the deal because whoever owns those 25 patents is going to control a great deal of the landscape for one of the most significant treatment areas in the entire addressable healthcare market.

That would seem to lay the groundwork for some type of bidding war at some stage down the road.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News